PAREXEL Release: Biopharma Announces Date Of Second Quarter Fiscal Year 2017 Earnings Release And Conference Call Post author:Sam Post published:January 19, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like 26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Proteostasis Therapeutics Snags Breakthrough Designation March 12, 2018
26-Employee Cue BioPharma Seeks $40 Million IPO Eight Months After Emerging From Stealth Mode September 25, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017